Search For "sars cov"
Virus that causes COVID-19 can find alternate route to infect cells: Study
Updated : 4 years, 8 months ago IST
Washington [US], June 25 (ANI): Early in the COVID-19 pandemic, scientists identified how SARS-CoV-2, the virus that causes COVID-19, gets inside cells to cause infection. All current COVID-19 vaccines and antibody-based therapeutics were designed to disrupt this route into cells, which requ
Read More
Genetic mechanism hijacked by COVID also makes it vulnerable to new class
Updated : 4 years, 8 months ago IST
Washington [US] June 24 (ANI): During a new study, researchers found a human genetic mechanism hijacked by SARS-CoV-2, the coronavirus behind the COVID-19 pandemic, to help it spread, which also makes it vulnerable to a new class of drug candidates.
Read More
Need to monitor any vaccine-escaping COVID-19 variants, says ICMR study in
Updated : 4 years, 8 months ago IST
New Delhi [India], June 24 (ANI): The result of a preliminary study conducted by the Indian Council for Medical Research (ICMR) scientists on 274 samples of breakthrough infections in Odisha has highlighted the need to monitor the emergence of any vaccine-escaping variants.
Read More
Study develops low-cost method for finding new COVID variants
Updated : 4 years, 8 months ago IST
Washington [US], June 23 (ANI): During a new study, researchers at Karolinska Institutet in Sweden developed a technology for cost-effective surveillance of the global spread of new SARS-CoV-2 variants.
Read More
Engineering nanobodies as lifesavers when SARS-CoV-2 variants attack
Updated : 4 years, 8 months ago IST
Washington [US], June 22 (ANI): Scientists at Ohio State University are pursuing a new strategy in the protracted fight against the SARS-CoV-2 virus by engineering nanobodies that can neutralise virus variants in two different ways.
Read More
COVID-19: INSACOG to release genomic surveillance bulletin on Delta Plus v
Updated : 4 years, 8 months ago IST
New Delhi [India], June 22 (ANI): Indian SARS-CoV-2 Genome Sequencing Consortia (INSACOG) - a consortium of four city clusters -- Bengaluru, Hyderabad, New Delhi and Pune -- will formally release the genomic surveillance bulletin on Delta Plus variant soon, according to government sources.
Read More
Researchers explore microbial ecosystem in search of drugs to fight SARS-C
Updated : 4 years, 8 months ago IST
Seoul [South Korea], June 21 (ANI): Researchers from Yonsei University in South Korea have found that certain commensal bacteria that reside in the human intestine produce compounds that inhibit SARS-CoV-2.
Read More
Study evaluates reason behind increased transmission in SARS-CoV-2 variant
Updated : 4 years, 8 months ago IST
Washington [US], June 21 (ANI): Recently a Johns Hopkins School of Medicine study found that although two SARS-CoV-2 variants are associated with higher transmission, patients with these variants show no evidence of higher viral loads in their upper respiratory tracts compared to the control
Read More
COVID-19: INSACOG to release report on Delta plus variant soon
Updated : 4 years, 9 months ago IST
New Delhi [India], June 18 (ANI): The Indian SARS-CoV-2 Consortium on Genomics, or INSACOG - a consortium of four city clusters - Bengaluru, Hyderabad, New Delhi and Pune, will soon release a report on Delta plus variant, government sources informed on Friday.
Read More
Thermo Fisher Scientific expands its SARS-CoV-2 testing portfolio in India
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 16 (ANI/PNN): Thermo Fisher Scientific today announced the introduction of the new and innovative Accula SARS-CoV-2 Test that delivers gold-standard reverse transcription-polymerase chain reaction (RT-PCR) detection of SARS-CoV-2 in a point-of-care format.
Read More
Single dose of vaccine produces more immunity in people who recovered from
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], June 14 (ANI): A single dose of Covishield vaccine given to those who had recovered from the SARS-CoV-2 infection showed these individuals had a stronger immunity to the Covid-19 virus compared to those having no prior exposure, according to a study.
Read More
Researchers find compound that blocks SARS-CoV-2, protects lung cells
Updated : 4 years, 9 months ago IST
Washington [US], June 14 (ANI): Research conducted at Louisiana State University Health New Orleans Neuroscience Center of Excellence reports that 'Elovanoids', bioactive chemical messengers made from omega-3 very-long-chain polyunsaturated fatty acids, may block the virus that causes COVID-
Read More